Table 2: Variables associated with survival of HIV-infected patients with hepatocellular carcinoma by Cox regression analysis

	Univariate Cox regression analysis			Multivariate Cox regression analysis
Variable	HR	95% CI	P	HR	95% CI	P
CDC category C	0.76	0.38-1.53	0.44
cART	0.75	0.27-2.14	0.59
CD4 cells (%)	0.99	0.95-1.02	0.42
Detectable HIV-RNA	1.89	0.97-3.67	0.06	0.72	0.34-1.49	0.37
HCV infection	1.16	0.35-3.80	0.81
Child-Pugh (A vs. BC)	0.87	0.45-1.69	0.68
Decompensation	0.87	0.45-1.67	0.68
MELD score	1.09	1.01-1.67	< 0.01	1.18	1.08-1.29	< 0.001
Alcohol consumption	0.65	0.28-1.48	0.30
BCLC (CD vs. 0AB)	16.89	6.02-47.43	< 0.001	9.97	2.58-38.52	0.001
AFP > 200 ng/ml	3.58	1.83-6.99	< 0.001	5.52	2.27-13.45	< 0.001
Any treatment	0.13	0.06-0.29	< 0.001	0.25	0.08-0.77	0.016
Screening of HCC	0.69	0.35-1.33	0.26
Diagnosis after 2006	0.64	0.33-1.22	0.17

Abbreviations: cART, combination antiretroviral therapy; MELD, Model for End-stage Liver Disease; BCLC, Barcelona-CliŽnic Liver Cancer staging system; AFP, alpha-fetoprotein; HCC, hepatocellular carcinoma.